Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy
The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Abstract
The highly immunosuppressive tumor microenvironment (TME) in solid tumors often dampens the efficacy of immunotherapy. In this study, bacterial outer membrane vesicles (OMVs) are demonstrated as powerful immunostimulants for TME reprogramming. To overcome the obstacles of antibody‐dependent clearance and high toxicity induced by OMVs upon intravenous injection (a classic clinically relevant delivery mode), calcium phosphate (CaP) shells are employed to cover the surface of OMVs, which enables potent OMV‐based TME reprograming without side effects. Meanwhile, the pH‐sensitive CaP shells facilitate the neutralization of acidic TME, leading to highly beneficial M2‐to‐M1 polarization of macrophages for improved antitumor effect. Moreover, the outer shells can be integrated with functional components like folic acid or photosensitizer agents, which facilitates the use of the OMV‐based platform in combination therapies for a synergic therapeutic effect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“OMVs with calcium phosphate (CaP) shells promoted cytotoxic T cell infiltration and M2 to M1 macrophage polarization, effectively improving the immunosuppressive TME [123] (Fig. 5H).”
From Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies (2022) · doi:10.1186/s13045-022-01273-9 · cites this paper as [123]
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Galon, J., & Bruni, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0007-y · Cited by 3,409
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Couzin-Frankel, J. (2013) · Science · doi:10.1126/science.342.6165.1432 · Cited by 2,051
Thommen, D. S., & Schumacher, T. N. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.012 · Cited by 1,299
Molecular tectonics in biomineralization and biomimetic materials chemistry
Mann, S. (1993) · Nature · doi:10.1038/365499a0 · Cited by 1,165
Rodell, C. B., Arlauckas, S. P., Cuccarese, M. F., Garris, C. S., Li, R., Ahmed, M. S., Kohler, R. H., Pittet, M. J., & Weissleder, R. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0236-8 · Cited by 1,099
Macrophage Regulation of Tumor Responses to Anticancer Therapies
De Palma, M., & Lewis, C. E. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.013 · Cited by 1,079
Engineered T cells: the promise and challenges of cancer immunotherapy
Fesnak, A. D., June, C. H., & Levine, B. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.97 · Cited by 1,074
Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Duan, X., Chan, C., & Lin, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201804882 · Cited by 1,033
TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
Yang, L., Pang, Y., & Moses, H. L. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.04.002 · Cited by 1,023
Immune modulation by bacterial outer membrane vesicles
Kaparakis-Liaskos, M., & Ferrero, R. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3837 · Cited by 1,019
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Chen, Q., Wang, C., Zhang, X., Chen, G., Hu, Q., Li, H., Wang, J., Wen, D., Zhang, Y., Lu, Y., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-018-0319-4 · Cited by 1,010
Self-citationObstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Anderson, K. G., Stromnes, I. M., & Greenberg, P. D. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.008 · Cited by 702
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Min, Y., Roche, K. C., Tian, S., Eblan, M. J., McKinnon, K. P., Caster, J. M., Chai, S., Herring, L. E., Zhang, L., Zhang, T., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.113 · Cited by 701
Armstrong, J. K., Hempel, G., Koling, S., Chan, L. S., Fisher, T., Meiselman, H. J., & Garratty, G. (2007) · Cancer · doi:10.1002/cncr.22739 · Cited by 699
Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response
Kim, O. Y., Park, H. T., Dinh, N. T. H., Choi, S. J., Lee, J., Kim, J. H., Lee, S.-W., & Gho, Y. S. (2017) · Nature Communications · doi:10.1038/s41467-017-00729-8 · Cited by 616
Huang, L., Li, Y., Du, Y., Zhang, Y., Wang, X., Ding, Y., Yang, X., Meng, F., Tu, J., Luo, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12771-9 · Cited by 596
1D Coordination Polymer Nanofibers for Low‐Temperature Photothermal Therapy
Yang, Y., Zhu, W., Dong, Z., Chao, Y., Xu, L., Chen, M., & Liu, Z. (2017) · Advanced Materials · doi:10.1002/adma.201703588 · Cited by 583
Regulatory circuits of T cell function in cancer
Speiser, D. E., Ho, P.-C., & Verdeil, G. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.80 · Cited by 566
Gujrati, V., Kim, S., Kim, S.-H., Min, J. J., Choy, H. E., Kim, S. C., & Jon, S. (2014) · ACS Nano · doi:10.1021/nn405724x · Cited by 543
Park, J., Wrzesinski, S. H., Stern, E., Look, M., Criscione, J., Ragheb, R., Jay, S. M., Demento, S. L., Agawu, A., Licona Limon, P., et al. (2012) · Nature Materials · doi:10.1038/nmat3355 · Cited by 494
Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
Morello, A., Sadelain, M., & Adusumilli, P. S. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0583 · Cited by 477
Lu, J., Liu, X., Liao, Y.-P., Salazar, F., Sun, B., Jiang, W., Chang, C. H., Jiang, J., Wang, X., Wu, A. M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01651-9 · Cited by 440
Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages
Bohn, T., Rapp, S., Luther, N., Klein, M., Bruehl, T.-J., Kojima, N., Aranda Lopez, P., Hahlbrock, J., Muth, S., Endo, S., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0226-8 · Cited by 436
Moon, E. K., Wang, L.-C., Dolfi, D. V., Wilson, C. B., Ranganathan, R., Sun, J., Kapoor, V., Scholler, J., Puré, E., Milone, M. C., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2627 · Cited by 404
Barouch, D. H., Pau, M. G., Custers, J. H. H. V., Koudstaal, W., Kostense, S., Havenga, M. J. E., Truitt, D. M., Sumida, S. M., Kishko, M. G., Arthur, J. C., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6290 · Cited by 383
Delivering safer immunotherapies for cancer
Milling, L., Zhang, Y., & Irvine, D. J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.011 · Cited by 305
Combining microenvironment normalization strategies to improve cancer immunotherapy
Mpekris, F., Voutouri, C., Baish, J. W., Duda, D. G., Munn, L. L., Stylianopoulos, T., & Jain, R. K. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919764117 · Cited by 286
Zhang, X., Du, J., Guo, Z., Yu, J., Gao, Q., Yin, W., Zhu, S., Gu, Z., & Zhao, Y. (2019) · Advanced Science · doi:10.1002/advs.201801122 · Cited by 251
Zhang, Y., Li, N., Suh, H., & Irvine, D. J. (2018) · Nature Communications · doi:10.1038/s41467-017-02251-3 · Cited by 248
Zhang, Y.-X., Zhao, Y.-Y., Shen, J., Sun, X., Liu, Y., Liu, H., Wang, Y., & Wang, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04296 · Cited by 220
Self-citationAn immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
Chen, Y., Xia, R., Huang, Y., Zhao, W., Li, J., Zhang, X., Wang, P., Venkataramanan, R., Fan, J., Xie, W., et al. (2016) · Nature Communications · doi:10.1038/ncomms13443 · Cited by 190
Nanoparticle‐Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses
Nuhn, L., De Koker, S., Van Lint, S., Zhong, Z., Catani, J. P., Combes, F., Deswarte, K., Li, Y., Lambrecht, B. N., Lienenklaus, S., et al. (2018) · Advanced Materials · doi:10.1002/adma.201803397 · Cited by 159
A Drug‐Free Tumor Therapy Strategy: Cancer‐Cell‐Targeting Calcification
Zhao, R., Wang, B., Yang, X., Xiao, Y., Wang, X., Shao, C., & Tang, R. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601364 · Cited by 143
Toll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactants
Hanzelmann, D., Joo, H.-S., Franz-Wachtel, M., Hertlein, T., Stevanovic, S., Macek, B., Wolz, C., Götz, F., Otto, M., Kretschmer, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12304 · Cited by 114
Schenk, M., Belisle, J. T., & Modlin, R. L. (2009) · Immunity · doi:10.1016/j.immuni.2009.11.008 · Cited by 108
Rosenberg, A. S., Verthelyi, D. I., & Cherney, B. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23244 · Cited by 103
Chen, W., Wang, G., Yung, B. C., Liu, G., Qian, Z., & Chen, X. S. (2017) · ACS Nano · doi:10.1021/acsnano.7b01809 · Cited by 84
Noh, Y., Kim, S., Kim, J., Kim, S., Ryu, J., Kim, I., Lee, E. J., Um, S. H., & Lim, Y. T. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201605398 · Cited by 78
Hong, E., & Dobrovolskaia, M. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.005 · Cited by 61
Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors
Xin, G., Schauder, D., Jing, W., Jiang, A., Joshi, N. S., Johnson, B. D., & Cui, W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614315114 · Cited by 36
Tumors sweeten macrophages with acids
Sekine, H., Yamamoto, M. P., & Motohashi, H. (2018) · Nature Immunology · doi:10.1038/s41590-018-0258-0 · Cited by 36
A Drug‐Free Tumor Therapy Strategy: Cancer‐Cell‐Targeting Calcification
Zhao, R., Wang, B., Yang, X., Xiao, Y., Wang, X., Shao, C., & Tang, R. (2016) · Angewandte Chemie · doi:10.1002/ange.201601364 · Cited by 15
Research works printed but not linked: 1
- Schwechheimer C., 2015, Nat. Rev. Immunol., 13, 605
Cited by
Inorganic nanomaterials with rapid clearance for biomedical applications
Wang, X., Zhong, X., Li, J., Liu, Z., & Cheng, L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00461h · Cited by 509
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
(2022) · doi:10.1186/s13045-022-01273-9 · Cited by 495
“OMVs with calcium phosphate (CaP) shells promoted cytotoxic T cell infiltration and M2 to M1 macrophage polarization, effectively improving the immunosuppressive TME [123] (Fig.”
BackgroundSelf-citationRecent applications of immunomodulatory biomaterials for disease immunotherapy
Dai, H., Fan, Q., & Wang, C. (2022) · Exploration · doi:10.1002/exp.20210157 · Cited by 268
Bioactive inorganic nanomaterials for cancer theranostics
Pei, Z., Lei, H., & Cheng, L. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00352j · Cited by 255
Nanomaterials in tumor immunotherapy: new strategies and challenges
Zhu, X., & Li, S. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01797-9 · Cited by 251
Metadata
- Authors
- Qing, S., Lyu, C., Zhu, L., Pan, C., Wang, S., Li, F., Wang, J., Yue, H., Gao, X., Jia, R., Wei, W., & Ma, G.
- Affiliations
- Chinese Academy of Sciences (CN)
- State Key Laboratory of Pathogen and Biosecurity Beijing Institute of Biotechnology No. 20 Dongda Street Beijing 100071 P. R. China
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Wei, Wei
- Ma, Guanghui
- ORCID
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2020-10-05
- Volume
- 32
- Issue
- 47
- Pages
- e2002085-e2002085
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W3090405704
- Cited by
- 309
- References
- 48
- Citations by year
- 2026: 31 · 2025: 72 · 2024: 75 · 2023: 56 · 2022: 42 · 2021: 31 · 2020: 1
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Advanced Materials (publishedVersion)
- PubMed (publishedVersion)
- Institute of Process Engineering, CAS Institutional Repository (submittedVersion)
- Funders
- National Natural Science Foundation of China (21821005)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- bacterial outer membrane vesicles, biomineralization, tumor microenvironment reprogramming, immunosuppression, M2 to M1 macrophage polarization, pH-responsive drug delivery, folic acid, photosensitizers, combination therapy, intravenous injection
- MeSH terms
- Extracellular Vesicles, Biomineralization, Bacterial Outer Membrane, Adjuvants, Immunologic, Immunotherapy, Macrophages, Safety, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.